IPH6501
innate
['innatepharma', 'innate pharma']
innate will share updated preclinical data on iph6501, a first-in-class tetra-specific nk cell engager, based on our proprietary anket platform, at the 2023 congress. read more #innatepharma #innateimmunity #nkcell #oncology #eha2023 
#Biotech #Immunotherapy #ImmunoOncology #Cancer #Inflammation #Antibody #Checkpoints